Equipoise was in fact developed in 1949, even before Dianabol (Methandrostenolone), making Equipoise technically the very first synthetic derivative of Testosterone even before Dianabol was ever thought of.
Equipoise is the brand/trade name for the anabolic steroid Boldenone, which is an oil-based injectable anabolic steroid with the Undecylenate ester attached to it for a prolonged release rate and half-life. It is a derivative of Testosterone that retains Testosterone’s anabolic strength but exhibits a reduced androgenic effect in comparison. Equipoise is primarily a veterinary product, originally intended for use in animals. Equipoise has gained popularity with bodybuilders and athletes as a less androgenic form of Testosterone with less Estrogenic activity than Testosterone as well. Many users enjoy comparing it to that of Deca Durabolin.
Equipoise being a derivative of TEST grants it many of the same properties. For one thing, it possesses the exact same anabolic strength rating (100), and it is also an aromatizable anabolic steroid, which means that Equipoise can and does convert into estrogen in the body through interaction with the aromatase enzyme. However, its double-bond modifications between carbons 1 and 2 reduce its affinity for the aromatase enzyme, granting it a lower rate of aromatization and therefore a lower Estrogenic activity in the body.
Equipoise Cycles can involve the added use of an oral compound, usually Dianabol (Methandrostenolone) at about 25mg per day. Testosterone Enanthate (or Cypionate) in this case can be reduced to 100mg per week in order to merely maintain normal physiological function, and Equipoise can be run at about 400 – 600mg per week. The Dianabol in this case is run from weeks 1 – 4, and the total cycle length is 12 weeks.
Female anabolic steroid users might find Equipoise a suitable compound due to its considerably lower androgenic capabilities than Testosterone. In this case, females should find it acceptable to use 50 – 75mg per week. An issue that may present itself is Equipoise’s very long half-life of 14 days, which will undoubtedly manifest as a slow reduction of blood plasma levels. With this comes a slow elimination of the compound from the body.